Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 38 (RPL36AP38)

Target: RPL36AP38
Molecular classification: Other

Overview

Ribosomal protein L36a pseudogene 38 (RPL36AP38) is a member of a large family of ribosomal protein pseudogenes that are processed copies of protein-coding ribosomal genes dispersed throughout the genome. Like most pseudogenes, RPL36AP38 does not produce a functional protein. There is no evidence that RPL36AP38 has biological activity, acts as a therapeutic target, or is involved in disease pathogenesis. Its designation as a pseudogene distinguishes it from true protein-coding ribosomal proteins or targets commonly implicated in disease or drug development[1][5].

Other names: RPL36A_16_1155RPL36AP38

Biological functions

Other

Disease associations

Other

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 38 (RPL36AP38).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 38 (RPL36AP38).

Explore the full profile